Old Web
English
Sign In
Acemap
>
authorDetail
>
Tanya O’Shea
Tanya O’Shea
Medicine
Dexamethasone
Bortezomib
Cohort
Refractory
4
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma
2021
CHI | Human Factors in Computing Systems
Treen C. M. Morris
M Drake
P Kettle
Tracey McGuigan
Maeve Leahy
Michael ODwyer
Helen Enright
Tanya O’Shea
Rakesh Popat
Heather Oakervee
Kwee Yong
Jamie Cavenagh
David A. Cairns
Alberto Alvarez-Iglesias
Gordon Cook
Show All
Source
Cite
Save
Citations (0)
Serum VEGF in patients (PTS) receiving bevacizimab (BEV) for early-stage breast cancer (ESBC): ICORG 08-10.
2017
Journal of Clinical Oncology
Norma O'Donovan
Alexandra Canonici
Imelda Parker
Tanya O’Shea
Brian Moulton
Giuseppe Gullo
John Kennedy
D. Tryfonopoulos
Naomi Walsh
John Crown
Show All
Source
Cite
Save
Citations (0)
It's a sure bet you're going to die: Existential terror promotes gambling urges in problem players
2014
Matthew Rockloff
Matthew Browne
En Li
Tanya O’Shea
Show All
Source
Cite
Save
Citations (2)
Bortezomib, Adriamycin Dexamethasone (PAD) Combination Therapies or Patients with Relapsed or Refractory Myeloma Previously Treated with VAD or VAD like Therapy.
2006
Blood
T. C. M. Morris
Mary Drake
P Kettle
Aishleen Brunton
J Cavenagh
Heather Oakervee
Michael O’Dwyer
Margaret Murray
Tanya O’Shea
Gordon Cook
Show All
Source
Cite
Save
Citations (1)
1